Daniel Barsanow: ETHIZIA vs TachoSil for Hemostasis During Open Liver Surgery
Daniel Barsanow, Senior Physician and Specialist in Visceral Surgery at Klinikum Oldenburg AöR, shared a post on X about a recent article by James V. Guarrera et al., published in HPB, adding:
“Safety and effectiveness of ETHIZIA versus TachoSil for hemostasis during open liver surgery: a randomized controlled multicenter trial – HPB”
Title: Safety and effectiveness of ETHIZIA versus TachoSil for hemostasis during open liver surgery: a randomized controlled multicenter trial
Authors: James V. Guarrera, Navpreet Kaur, Cornelis Verhoef, Ivan Zendejas, Jean Botha, Suomi M.G. Fouraschen, Flavio Paterno, Frank Pianka, Robert J. Porte, Benjamin Samstein, Linda Sher, Jason R. Wellen, Johan C.M.E. Bender, Ingrid Fossan, Stuart J. Head, Johannes H.W. de Wilt, ETHIZIA Open Liver Study Collaborator Group
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 19, 2026, 18:10Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care and Access to Treatment in Fiji
-
Aug 19, 2026, 17:58Paulomi Ghosh: Delighted to Deliver a Talk on Hemostasis and Hemorrhage Control
-
Aug 19, 2026, 17:34Ryan O’Keefe: Clopidogrel Non-Responders and the Risk of Stent Thrombosis
-
Aug 19, 2026, 17:10Mavis Agnes Kisakye: Raising Awareness and Supporting Patients With Bleeding Disorders
-
Aug 19, 2026, 15:32Muhammad Abdullah: Comparing Oral Iron Treatments for Children With Anemia
-
Aug 19, 2026, 13:51Lucie Ellis-Taitt: Why Hemophilia Gene Therapies Are Failing?
-
Aug 19, 2026, 13:46Ahmed Bahi: Improving Hemophilia and Rare Disease Care in the Middle East
-
Aug 19, 2026, 13:34Edward Lee Carter: Can EZPLAZ Bring Plasma to Patients Earlier?
-
Aug 19, 2026, 12:59David McIntosh: The Growing Global Demand for Plasma-Derived Therapies